Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Vallejo v. Amgen, Inc. et al
Case Number:
8:14-cv-00050
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
July 18, 2017
Atty Stuck With $25K Sanction In Enbrel Discovery Row
The lawyer leading a lawsuit alleging that a psoriasis and arthritis prescription drug led to a man's death will have to pay a $25,000 sanction for trying to relitigate issues already settled in discovery, a Nebraska federal judge ruled Monday.
-
May 31, 2017
Attys Face $25K In Fees After Enbrel Suit Discovery Row
Attorneys for an estate suing the maker of Enbrel, alleging that the drug caused a man's death, were ordered to pay more than $25,000 in sanctions for going "beyond advocating" by relitigating already-denied motions without evidentiary support, a Nebraska court ruled on Tuesday.